As of July 1, 2019, the below number of individuals have been recruited in Swedegene. DNA and clinical data collection for these are completed.

ADR type	Number
Angioedema	514
Anaphylaxis	112
Urticaria	152
Other allergic reactions	51
Cough related to ACE-inhibitors	152
Osteonecrosis and atypical fractures due to bisphosphonates	119
Phototoxic reactions (mainly due to topical NSAIDs)	50
Blood cell dyscrasia (agranulocytosis, thrombocytopenia and anemia) to non-cytostatic drugs	270
Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)	46
Hyponatremia/SIADH due to antidepressants and antiepileptics	35
CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics	94
Stevens-Johnson syndrome/Toxic epidermal necrolysis	63
Tendon-rupture from flouroquinolones	25
Liver toxicity	461
Rhabdomyolysis related to statins/fibrates	51
Torsade de Pointes/QT-prolongation	22
Narcolepsy associated with Pandemrix	83
Pancreatitis	82
Alopecia	28
Bleedings from new oral anticoagulants (NOACs)	60
Pneumonitis	20
Renal toxicity	70
Controls	580
Total number of cases	3140

ACE = angiotensin converting enzyme; NSAID = non-steroidal anti-inflammatory drug; NOAC=non-vitamin K oral anticoagulant drug.

Note that the number of cases for a particular ADR may be greater than the total number of cases as some individuals have experienced multiple ADRs concomitantly.